Skip to main content
Figure 1 | BMC Musculoskeletal Disorders

Figure 1

From: Do COX-2 inhibitors provide additional pain relief and anti-inflammatory effects in patients with rheumatoid arthritis who are on biological disease-modifying anti-rheumatic drugs and/or corticosteroids? Post-hoc analyses from a randomized clinical trial with etoricoxib

Figure 1

Least square means (95% CI) change from baseline in efficacy endpoints by trial treatments and concomitant therapy. A) pain (0–100 mm VAS); B) swollen joint count (number of joints); C) tender joint count (number of joints); D) health assessment questionnaire (points).

Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us